Iron limitation and expression of immunoreactive outer membrane proteins in Leptospira interrogans serovar icterohaemorrhagiae strain lai

Indian Journal of Medical Microbiology

Volumn 24, Issue 4, 2006, Pages 339-342

  Velineni, S ^a   Asuthkar, S ^a   Sritharan, M ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; OUTER MEMBRANE PROTEIN; PROTEIN LIPL32; PROTEIN LIPL41; TRITON X 114; UNCLASSIFIED DRUG;

BACTERIAL GROWTH; BACTERIAL STRAIN; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRON TRANSPORT; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; IRON DEPLETION; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; SEROTYPE;

EID: 33845936904     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.29414     Document Type: Conference Paper

References (19)

1. Litwin CM, Calderwood SB. Role of iron regulation of virulence genes. Clin Microbiol Rev 1993;6:137-49.
2. Braun V, Hantke K, Koster W. Bacterial iron transport: Mechanisms, genetics and regulation. In: Metal Ions in Biological systems. Iron transport and storage in Microorganisms, Plants and Animals. Sigel A, Sigel H, editors. Marcel Dekker: New York; 1998. p. 67.
3. Sritharan M. Iron as a candidate in virulence and pathogenesis in mycobacteria and other microorganisms. W J Microbiol Biotechnol 2000;16:769-80.
4. Gray-Owen SD, Schryvers AB. Bacterial transferrin and lactoferrin receptors. Trends Microbiol 1996;4:185-91.
5. Griffiths E, Chart H. Iron as a regulatory signal. In: Iron and Infection: Molecular, Physiological and Clinical Aspects. Bullen JJ, Griffiths E, editors. John Wiley and Sons: 1999. p. 213.
6. Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14:296- 326.
7. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: A zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-71.
8. Vintez JM. Leptospirosis. Curr Opin Infect Dis 2001;14:527-38.
9. Natarajaseenivasan K, Vijayachari P, Sugunan AP, Sharma S, Sehgal SC. Leptospiral proteins expressed during acute and convalescent phases of human leptospirosis. Indian J Med Res 2004;120:151-9.
10. Farrely HE, Adler B, Faine S. Opsonic monoclonal antibodies against lipopolysaccharides antigens of Leptospira interrogans serovar Hardjo. J Med Microbiol 1987;23:1-7.
11. Bulach DM, Kalambaheti T, De la Pena-Moctezuma A, Adler B. Lipopolysaccharide biosynthesis in Leptospira. J Mol Microbiol Biotechnol 2000;2:375-80.
12. Cullen PA, Cordwell SJ, Bulach DM, Haake DA, Adler B. Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun 2002;70:2311-8.
13. Cullen PA, Haake DA, Bulach DM, Zuerner RL, Adler B. LipL 21 is a novel surface exposed lipoprotein of pathogenic Leptospira species. Infect Immun 2003;71:2414-21.
14. Haake DA, Matsunaga J. Characterization of leptospiral outer membrane and description of three novel leptospiral membrane proteins. Infect Immun 2002;70:4936-45.
15. Gamberini M, Gomez RM, Atzingen MV, Martins EA, Vasconcellos SA, Romero EC, et al. Whole genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol Lett 2005;244:305-13.
16. Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, Mazel M, et al. The leptospiral major outer membrane protein LipL 32 is a lipoprotein expressed during mammalian infection. Infect Immun 2000;68:2276- 85.
17. Haake DA, Martinich C, Summers TA, Shang ES, Pruetz JD, Mc Coy AM. Characterisation of leptospiral outer membrane lipoprotein LipL36: Down-regulation associated with late-log phase growth and mammalian infection. Infect Immun 1998;66:1579-87.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
19. Towbin H, Staehelin T, Gordan J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.